Clinical trial
A Clinical Trial in Healthy Infants to Assess Lot-to-lot Consistency of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Non-inferiority With Respect to an Earlier Product.
NCT01567865 is registered in ClinicalTrials.gov with PATH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial in Healthy Infants to Assess Lot-to-lot Consistency of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Non-inferiority With Respect to an Earlier Product.
- Lead sponsor
- PATH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- December 31, 2012
- Enrollment
- 818 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
japanese encephalitis